Athira Pharma
ATHA
ATHA
83 hedge funds and large institutions have $59.5M invested in Athira Pharma in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 32 increasing their positions, 30 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
24% less capital invested
Capital invested by funds: $77.9M → $59.5M (-$18.4M)
67% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 15
Holders
83
Holding in Top 10
1
Calls
$942K
Puts
$210K
Top Buyers
| 1 | +$3.48M | |
| 2 | +$2.88M | |
| 3 | +$1.24M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$1.18M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$807K |
Top Sellers
| 1 | -$8.01M | |
| 2 | -$5.96M | |
| 3 | -$1.53M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$331K |
| 5 |
PVI
Pura Vida Investments
New York
|
-$246K |